David Shaw D.E. Shaw & Co
David Shaw founded D. E. Shaw & Co., a pioneering quantitative investment firm that helped define systematic trading at scale. With a background in computer science, Shaw built teams that applied advanced computation to markets across equities, derivatives, and other assets. The firm remains one of the most important quant platforms in global finance, even as Shaw’s own public role has shifted over time.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$862M |
| 2 |
Baidu
BIDU
|
+$752M |
| 3 |
Tencent Music
TME
|
+$426M |
| 4 |
Coca-Cola
KO
|
+$424M |
| 5 |
NVIDIA
NVDA
|
+$383M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$981M |
| 2 |
Wells Fargo
WFC
|
+$673M |
| 3 |
Berkshire Hathaway Class B
BRK.B
|
+$574M |
| 4 |
Moderna
MRNA
|
+$442M |
| 5 |
DuPont de Nemours
DD
|
+$415M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.45% |
| 2 | Consumer Discretionary | 10.49% |
| 3 | Communication Services | 9.04% |
| 4 | Healthcare | 8.89% |
| 5 | Financials | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
976
PUT
Marriott International
MAR
$93.9B
| $16.1M | 0.02% |
108,700
+73,000
| +204% | +$9.97M |
|
977
CALL
Northrop Grumman
NOC
$78B
| $16.1M | 0.02% |
49,700
-21,200
| -30% | -$6.39M |
|
978
Occidental Petroleum
OXY
$60.1B
| $16.1M | 0.02% |
604,091
-2,320,426
| -79% | -$58M |
|
979
Southern Company
SO
$104B
| $16.1M | 0.02% |
258,454
-412,030
| -61% | -$24.7M |
|
|
COHR
980
DELISTED
Coherent Inc
COHR
| $16.1M | 0.02% |
63,492
-28,715
| -31% | -$6.38M |
|
|
DM
981
DELISTED
Desktop Metal, Inc.
DM
| $16M | 0.02% |
107,500
| – | – |
|
982
Ingredion
INGR
$6.69B
| $16M | 0.02% |
178,116
-170,502
| -49% | -$14.6M |
|
983
AngloGold Ashanti
AU
$60.9B
| $16M | 0.02% |
728,037
+479,437
| +193% | +$10.8M |
|
984
Spotify
SPOT
$111B
| $15.8M | 0.02% |
59,079
+44,152
| +296% | +$13.8M |
|
985
3M
MMM
$92.3B
| $15.8M | 0.02% |
97,932
+36,511
| +59% | +$5.47M |
|
|
AMRN
986
Amarin Corp
AMRN
$292M
| $15.8M | 0.02% |
127,017
-65,583
| -34% | -$8.82M |
|
987
O-I Glass
OI
$1.11B
| $15.8M | 0.02% |
1,070,131
+45,429
| +4% | +$585K |
|
|
SLCA
988
DELISTED
U.S. SILICA HOLDINGS, INC.
SLCA
| $15.8M | 0.02% |
1,282,688
-241,713
| -16% | -$2.63M |
|
989
Teledyne Technologies
TDY
$29B
| $15.7M | 0.02% |
38,045
+10,183
| +37% | +$3.93M |
|
990
Arcus Biosciences
RCUS
$3.84B
| $15.7M | 0.02% |
559,309
-10,024
| -2% | -$349K |
|
991
PUT
eBay
EBAY
$47.7B
| $15.7M | 0.02% |
256,000
-232,600
| -48% | -$13.5M |
|
992
Sony
SONY
$142B
| $15.7M | 0.02% |
739,000
+713,490
| +2,797% | +$15.1M |
|
993
Ormat Technologies
ORA
$6.48B
| $15.7M | 0.02% |
+199,498
| New | +$19.8M |
|
994
The RealReal
REAL
$1.37B
| $15.7M | 0.02% |
692,153
+88,371
| +15% | +$2.17M |
|
995
PUT
Costco
COST
$431B
| $15.6M | 0.02% |
44,300
-24,700
| -36% | -$8.6M |
|
996
Qiagen
QGEN
$8.63B
| $15.6M | 0.02% |
302,586
-225,121
| -43% | -$12.4M |
|
997
CALL
Illumina
ILMN
$33.7B
| $15.6M | 0.02% |
41,634
+21,794
| +110% | +$8.89M |
|
998
Blackrock
BLK
$182B
| $15.5M | 0.02% |
20,618
+12,660
| +159% | +$9.18M |
|
999
Euronet Worldwide
EEFT
$2.63B
| $15.5M | 0.02% |
112,375
+24,576
| +28% | +$3.55M |
|
|
GRA
1000
DELISTED
W.R. Grace & Co.
GRA
| $15.5M | 0.02% |
259,303
-145,125
| -36% | -$8.66M |
|
Similar funds
David Shaw's Q1 2021 Portfolio in Review
As of Q1 2021, David Shaw held 4,712 positions worth $104B, down 7.4% from $112B the previous quarter. Its ten largest holdings account for 9.9% of the portfolio.
David Shaw withdrew a net $18.3B in Q1 2021, closing 730 positions and reducing 1,773 holdings. Its most notable exit was AstraZeneca, an estimated $214M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 15% a quarter earlier, followed by Consumer Discretionary and Communication Services.
Against the trend, David Shaw opened a new position in Baidu worth $627M.
- David Shaw's largest Q1 2021 buy was Baidu: 2,881,724 shares worth $627M.
- David Shaw added most to Tesla in Q1 2021, an estimated $862M increase.
- David Shaw's biggest Q1 2021 reduction was Amazon, cutting an estimated $981M.
- David Shaw fully exited AstraZeneca in Q1 2021, selling an estimated $214M.
- David Shaw's ten largest holdings make up 9.9% of its $104B portfolio in Q1 2021.
- David Shaw opened 825 new positions and closed 730 in Q1 2021.
- David Shaw's portfolio value fell 7.4% quarter-over-quarter to $104B.
Based on D.E. Shaw & Co's 13F filing for Q1 2021, filed 17 May 2021.